Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients
recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to
placebo.